Efficacy and safety of favipiravir plus interferon-beta versus lopinavir/ritonavir plus interferon-beta in moderately ill patients with COVID-19: A randomized clinical trial
Hassaniazad et al., Journal of Medical Virology, doi:10.1002/jmv.27724
https://c19early.org/hassaniazad2.html